Skip to content

EPS (Diluted) at other companies

Abbott logo
AbbottABT
$0.61-19.7%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$1.11-204%
TFX
TeleflexTFX
-$0.18-109%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.14-52.9%
Stryker logo
StrykerSYK
$1.93+14.2%
Boston Scientific logo
Boston ScientificBSX
$0.90+100%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%
Enterprise value$4.34B-33.3%
P/E28.8×-21.0×
P/S2.6×-1.8×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's EPS (diluted)?
Merit Medical Systems (MMSI) reported EPS (diluted) of $0.68 in Q1 2026.
How has Merit Medical Systems's EPS (diluted) changed year-over-year?
Merit Medical Systems's EPS (diluted) increased by 38.8% year-over-year, from $0.49 to $0.68.
What is the long-term trend for Merit Medical Systems's EPS (diluted)?
Over 4 years (2021 to 2025), Merit Medical Systems's EPS (diluted) has grown at a 26.2% compound annual growth rate (CAGR), from $0.84 to $2.13.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.